Home
About
Overview
Sharing Data
ORCID
Help
History (4)
A phase II study of bevacizumab and temsirolimus in advanced extra-pancreatic neuroendocrine tumors.
Biguanides
Cost-effectiveness of Initiating an Insulin Pump in T1D Adults Using Continuous Glucose Monitoring Compared with Multiple Daily Insulin Injections: The DIAMOND Randomized Trial.
Leukemia, Promyelocytic, Acute
See All 4 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
A phase II study of bevacizumab and temsirolimus in advanced extra-pancreatic neuroendocrine tumors.
A phase II study of bevacizumab and temsirolimus in advanced extra-pancreatic neuroendocrine tumors. Endocr Relat Cancer. 2023 11 01; 30(11).
View in:
PubMed
subject areas
Bevacizumab
Combined Modality Therapy
Humans
Neoplasms, Second Primary
Neuroendocrine Tumors
Pancreatic Neoplasms
authors with profiles
Hedy Kindler